1 min read
Add as a preferred source on GoogleRichards Group Posts 1.8% Q3 Revenue Growth After PharmaSystems Deal
Gross margins rose 6.5% year over year, while Packaging revenue fell 7.3%, a smaller decline than in the first half.
Richards Group Inc. posted 1.8% year-over-year revenue growth in the third quarter of 2026, with contributions from its May acquisition of PharmaSystems providing the main lift.
Gross margins increased 6.5% from a year earlier, supported by a stronger Healthcare mix. Growth in Healthcare came from consumables and low-price capital equipment.
Packaging revenue declined 7.3% year over year. The decline was smaller than the 14.4% drop in the first half of 2026.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.